(Q36911203)

17 August 2017

1 reference

title

Methicillin-resistant Staphylococcus aureus--an overview (English)

1 reference

methicillin-resistant Staphylococcus aureus

17 August 2017

main subject

0 references

Staphylococcus aureus

object named as

Staphylococcus aureus

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00335.X

19 November 2022

author name string

H. J. Eadon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1770073

19 November 2022

R. J. Pinney

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1770073

19 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1770073

19 November 2022

publication date

1 December 1991

1 reference

full work available at URL

17 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2710.1991.tb00335.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00335.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2710.1991.tb00335.x/fullpdf

19 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00335.X

Journal of Clinical Pharmacy and Therapeutics

19 November 2022

published in

1 reference

17 August 2017

volume

16

1 reference

17 August 2017

issue

6

1 reference

17 August 2017

page(s)

453-462

1 reference

Staphylococcus aureus. The persistent pathogen (first of two parts).

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

Pharmacokinetics in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

Staphylococcus aureus. The persistent pathogen (second of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

What's in a name? Is methicillin-resistant Staphylococcus aureus just another S aureus when treated with vancomycin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

Genetics of methicillin resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

Gentamicin and antiseptic resistance in epidemic methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

Influence of LY146032 on human polymorphonuclear leucocytes in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

Low-level methicillin resistance in strains of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

New mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

Penicillin-binding proteins and the mechanism of action of beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

Natural methicillin resistance in comparison with that selected by in-vitro drug exposure in Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

New genetic location of gentamicin-resistance in methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

Current problems with methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

Transferable mupirocin-resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

21 January 2018

The spiramycin paradox

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

Adaptation of methicillin-resistant Staphylococcus aureus during antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

Mupirocin resistance in staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

Sensitivity of methicillin-resistant Staphylococcus aureus strains to some antibiotics, antiseptics and disinfectants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

Vancomycin for treatment of infections with methicillin-resistant Staphylococcus aureus: are there alternatives?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

Teicoplanin in infections caused by methicillin-resistant staphylococci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

In vitro activity of LY 264826 compared with that of vancomycin against 100 clinical isolates each of methicillin-resistant Staphylococcus aureus and Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00335.X

Induction of chromosomal beta-lactamases by different concentrations of clavulanic acid in combination with ticarcillin

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00335.X

Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results

19 November 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00335.X

Methicillin-resistant staphylococci.

19 November 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00335.X

Methicillin-resistant Staphylococcus aureus

19 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00335.X

Involvement of multiple genetic determinants in high-level methicillin resistance in Staphylococcus aureus

19 November 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00335.X

Strategies for molecular characterisation of methicillin- and gentamicin-resistant Staphylococcus aureus in a Canadian nosocomial outbreak

19 November 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00335.X

Comparison of test systems for recognition of methicillin resistance in Staphylococcus aureus

19 November 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00335.X

The value of nasal mupirocin in containing an outbreak of methicillin-resistant Staphylococcus aureus in an orthopaedic unit

19 November 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00335.X

Transmissible mupirocin resistance in Staphylococcus aureus

19 November 2022

36

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00335.X

Staphylococcus aureus resistant to mupirocin

19 November 2022

39

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00335.X

Mupirocin-resistant Staphylococcus aureus

19 November 2022

41

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00335.X

Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance.

19 November 2022

46

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00335.X

19 November 2022

Identifiers

1 reference

17 August 2017

1 reference